Nov 24 (Reuters) - Sigma Pharmaceuticals Ltd SIP.AX -
* Sigma partnership with Fred It Group-sip.ax
* "Remain on track to deliver our previously upgraded guidance of underlying ebit growth of 10% for current fy and at least 5% for fy2018" Source text for Eikon: ID:nASX9MFlhb Further company coverage: SIP.AX